Victory Capital Management Inc Novartis Ag Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$92.27 - $101.54 $1.4 Million - $1.54 Million	-15,130 Reduced 70.73%	6,260 $632,000
Q2 2023 Jul 27, 2023	SELL	$92.52 - $104.91 $174,215 - $197,545	-1,883 Reduced 8.09%	21,390 $2.16 Million
Q1 2023 May 02, 2023	BUY	$80.03 - $92.81 $1.86 Million - $2.16 Million	23,273 New	23,273 $2.14 Million
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $1.76 Million - $2.15 Million	23,273 New	23,273 $2.11 Million
Q4 2019 Feb 04, 2020	SELL	$84.35 - $95.37 $1.23 Million - $1.39 Million	-14,607 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $1.25 Million - $1.38 Million	14,607 New	14,607 $1.27 Million
Q3 2018 Nov 01, 2018	SELL	$66.94 - $77.43 $5.06 Million - $5.85 Million	-75,530 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$64.91 - $73.36 $639,947 - $723,256	-9,859 Reduced 11.55%	75,530 $5.71 Million
Q1 2018 May 04, 2018	BUY	$70.39 - $84.15 $6.01 Million - $7.19 Million	85,389 New	85,389 $6.9 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.